NEWS RELEASE

October 14, 2023 UCBN News, Syndication Comments Off on NEWS RELEASE

For Immediate Release: October 13, 2023

Colorado BioScience Association to Honor Life Sciences Companies at 20th Annual Awards Celebration, Presented by AGC Biologics      

Enliven Therapeutics, PharmaJet, and TriSalus Life Sciences Named as Company of the Year Finalists; Arpeggio Biosciences, Foresight Diagnostics, and Lazzaro Medical Selected as Rising Star of the Year Finalists

Denver – Colorado BioScience Association (CBSA) today announced the finalists for two of its prestigious annual awards, Company of the Year and Rising Star of the Year, Sponsored by Willis Towers Watson. The awards honor established and emerging companies for notable achievements during the year. The winners will be revealed during the 20th Annual Awards Celebration, Presented by AGC Biologics, to be held at the Seawell Ballroom in the Denver Center for the Performing Arts on November 16.

“Congratulations to our Company of the Year finalists, Enliven Therapeutics, PharmaJet, and TriSalus Life Sciences, and…
Click here to view original post

Related Articles

News

Panacea Life Sciences Holdings (OTCID: PLSH) and Benivita Inc. Launch Benivita PLSH — a New Era in Direct-to-Consumer Virtual Benefits

November 18, 2025 UCBN News, Syndication Comments Off on Panacea Life Sciences Holdings (OTCID: PLSH) and Benivita Inc. Launch Benivita PLSH — a New Era in Direct-to-Consumer Virtual Benefits

GOLDEN, Colo., Nov. 18, 2025 /PRNewswire/ — Panacea Life Sciences Holdings, Inc. (“PLSH”) today announced the launch of Benivita PLSH, a groundbreaking venture with Benivita Inc., designed to revolutionize access to non-insurance benefits, virtual telemedicine […]

News

University of Colorado Anschutz Medical Campus Awarded One of the Largest Clinical Trial Grants in Campus History to Lead Trauma Study

July 31, 2025 UCBN News, Syndication Comments Off on University of Colorado Anschutz Medical Campus Awarded One of the Largest Clinical Trial Grants in Campus History to Lead Trauma Study

The University of Colorado Anschutz Medical Campus will lead a groundbreaking national clinical trial—supported by a $29 million grant from Octapharma—to evaluate whether early replacement of fibrinogen, a critical blood clotting mechanism in the body, […]